3 doctors weighed in:

How effective is regorafenib for colon cancer mets?

3 doctors weighed in
Dr. Eric Chevlen
Internal Medicine - Oncology
2 doctors agree

In brief: Depends

One study showed a response rate of 40%.
"Response" in this context, means the tumor shrunk. It is rare for tumors to disappear on regorafenib. Clinical benefit depends to a great extent on the overall fitness of the patient (performance status), extent of disease, and number of prior therapies. Courage and faith, Marilyn994, and my best wishes for you.

In brief: Depends

One study showed a response rate of 40%.
"Response" in this context, means the tumor shrunk. It is rare for tumors to disappear on regorafenib. Clinical benefit depends to a great extent on the overall fitness of the patient (performance status), extent of disease, and number of prior therapies. Courage and faith, Marilyn994, and my best wishes for you.
Dr. Eric Chevlen
Dr. Eric Chevlen
Thank
Dr. Andrew Seibert
Internal Medicine - Gastroenterology

In brief: Regorafenib

...is a tyrosine kinase inhibitor which has been shown to have some activity against metastatic colon cancer.
When used as part of a colon cancer treatment regimen by an oncologist, it has been shown to increase overall survival. It does have some worrisome potential side effects, however. It would certainly be worthwhile to discuss this with your oncologist. Good luck.

In brief: Regorafenib

...is a tyrosine kinase inhibitor which has been shown to have some activity against metastatic colon cancer.
When used as part of a colon cancer treatment regimen by an oncologist, it has been shown to increase overall survival. It does have some worrisome potential side effects, however. It would certainly be worthwhile to discuss this with your oncologist. Good luck.
Dr. Andrew Seibert
Dr. Andrew Seibert
Thank
Get help from a real doctor now
Dr. Mark Pack
Board Certified, Surgery
28 years in practice
3M people helped
Continue
111,000 doctors available
Read more answers from doctors